Treatment with mesenchymal stem cells reverses ductular reaction in cirrhotic liver
间充质干细胞 (MSC) therapy shows promise in reversing ductular reaction (DR) in cirrhosis. Research reveals MSC treatment significantly reduces DR severity, offering a potential novel therapeutic approach for liver disease progression. Learn more about this groundbreaking study.